All In Biotech

Drug Trial Radar · NCT00388297

Thyroid Therapy for Mild Thyroid Deficiency in Pregnancy

A Randomized Trial of Thyroxine Therapy for Subclinical Hypothyroidism or Hypothyroxinemia Diagnosed During Pregnancy

Last checked: Nov 19, 2026Latest source record: Feb 21, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,203 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,203

Actual

Start

Oct 2006

Primary completion

Aug 2015

Study completion Oct 2015

Sponsor

Lead sponsor
The George Washington University Biostatistics CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
First posted
Oct 16, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Single group
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
Female only
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether treating women, who are diagnosed with a mild imbalance of thyroid hormones during pregnancy, with thyroid hormone replacement affects their children's intellectual development at 5 years of age.

Conditions

  • Subclinical Hypothyroidism
  • Hypothyroxinemia
  • Pregnancy

Interventions

  • LevothyroxineDrug

    Coded study drug is thyroxine encapsulated in a gel capsule; matching placebo contains only cellulose. Color of capsule corresponds to mcg dose level (100mcg or 25 mcg). Subjects in subclinical hypothyroidism stratum are started on 1 capsule of 100 mcg per day; subjects in hypothyroxinemia stratum are started on 2 capsules of 25 mcg per day. Thyroxine dosing adjustments for both strata are determined centrally, using an algorithm, based on results of monthly TSH or free-T4 assays. Subjects take study medication until delivery.

  • Placebo for LevothyroxineDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Intellectual Function of Children at 5 Years of Age in Women Diagnosed With a) Subclinical Hypothyroidism or b) Hypothyroxinemia During the First Half of Pregnancy, or Death.Time frame: 60 months of age

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama - Birmingham

    Birmingham, Alabama

  • Northwestern University

    Chicago, Illinois

  • Wayne State University

    Detroit, Michigan

  • Columbia University

    New York, New York

  • University of North Carolina - Chapel Hill

    Chapel Hill, North Carolina

  • Case Western University

    Cleveland, Ohio

  • Ohio State University

    Columbus, Ohio

  • Oregon Health & Sciences University

    Portland, Oregon

  • University of Pittsburgh Magee Womens Hospital

    Pittsburgh, Pennsylvania

  • Brown University

    Providence, Rhode Island

  • University of Texas - Southwest

    Dallas, Texas

  • University of Texas Medical Branch - Galveston

    Galveston, Texas

  • University of Texas-Houston

    Houston, Texas

  • University of Utah Medical Center

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.